Bandu Pharmaceuticals Private Limited
About Bandu Pharmaceuticals Private Limited
Data last updated:
Bandu Pharmaceuticals Private Limited is a private limited company based in Vasai, Maharashtra, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 22 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2019PTC325644. Its GSTIN is 27AAICB4540R1Z5 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Priyanka Mangesh Ghumare and Rupesh Bapuram Shrungare.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No.03 Peninsula Heights Bldg No.04, Near D Mart Vasai Palghar Vasai – Virar City M Corp, Maharashtra, India – 401303.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.57 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net profit of ₹10,355 (net margin 1.2%) and EBITDA of ₹20,734 (EBITDA margin 2.4%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Bandu Pharmaceuticals Private Limited's registered office is in Vasai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No.03 Peninsula Heights Bldg No.04, Near D Mart Vasai Palghar Vasai – Virar City M Corp, Maharashtra, India – 401303
- IndustryHealthcare, Human Health Activities
To see the full contact details of Bandu Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bandu Pharmaceuticals is information and communication. In detail, this covers wired, wireless or satellite telecommunication activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J5 | Wired, wireless or satellite Telecommunication activities |
To see the full business activity and turnover split of Bandu Pharmaceuticals Private Limited, buy the company report.
Financials of Bandu Pharmaceuticals Private Limited
FY 2025 filings availableBandu Pharmaceuticals Private Limited reported revenue of ₹8.57 Lakh (down 45% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 26% over three years, including a 45% fall in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,734 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10,355 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bandu Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bandu Pharmaceuticals Private Limited
Bandu Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Mangesh Ghumare | Director | 22 May 2019 | 7 Years 5 Months | Current |
| Rupesh Bapuram Shrungare | Director | 22 May 2019 | 7 Years 5 Months | Current |
| Mangesh Jayanand Ghumare | Additional Director | 26 Jun 2021 | 5 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Bandu Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bandu Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bandu Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICB4540R1Z5 | Maharashtra | Active | 01 Oct 2019 |
To see the full GST registrations and return filing status of Bandu Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bandu Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Mangesh Jayanand Ghumare was appointed as Additional Director on 26 Jun 2021.
Frequently asked questions
Bandu Pharmaceuticals is an active private limited company based in Vasai, Maharashtra, India. The company works in human health activities, within the healthcare industry. It was incorporated on 22 May 2019 (7+ years old) and is registered under CIN U85100MH2019PTC325644.
Bandu Pharmaceuticals has 3 current directors:
- Priyanka Mangesh Ghumare - Director
- Rupesh Bapuram Shrungare - Director
- Mangesh Jayanand Ghumare - Additional Director
The latest financial statements of Bandu Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Bandu Pharmaceuticals is 27AAICB4540R1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bandu Pharmaceuticals is U85100MH2019PTC325644. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bandu Pharmaceuticals was incorporated on 22 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Mangesh Jayanand Ghumare was appointed as Additional Director on 26 Jun 2021. Priyanka Mangesh Ghumare was appointed as Director on 22 May 2019. Rupesh Bapuram Shrungare was appointed as Director on 22 May 2019.
The registered office of Bandu Pharmaceuticals is at Shop No.03 Peninsula Heights Bldg No.04, Near D Mart Vasai Palghar Vasai – Virar City M Corp, Maharashtra, India – 401303.
Bandu Pharmaceuticals operates in the healthcare industry, in the human health activities segment.
The compliance status of Bandu Pharmaceuticals is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
